Injectables manufacturing ushers in a new era of accessibility
The pharmaceutical injectables market is gaining more traction as vaccines and the development of biological drugs such as cell and…
The pharmaceutical injectables market is gaining more traction as vaccines and the development of biological drugs such as cell and…
As biosimilars continue to arrive on the psoriasis scene, wider measures to influence drug access and emerging treatment choices in the US healthcare system are causing a treatment paradigm shift.…
In the post-Covid-19 era, drug shortages are putting extra strain on pharmacists and patients. Pharmacists are trying to manage stock levels and process prescriptions quickly while protecting patients’ health and…
Born from the urgent need to protect consumers from unsafe medications and a push from legislatures, the US Drug Supply Chain Security Act (DSCSA) is almost here, in full. The…
A year after bursting onto the scene amid the RNA renaissance, scientific challenges and regulatory resistance have held back self-amplifying messenger RNA (samRNA) vaccines from taking over the vaccine space.…
Innovative cell and gene therapies (CGTs) have significantly disrupted the treatment landscape for several genetic diseases. In recent years, the number of CGT approvals has been on an upward trajectory,…
The growing global demand for cell and gene therapies (CGTs) is resulting in a manufacturing paradigm shift, reflecting the need to overcome a range of evolving new challenges and adapt…